Company: SMNR
Filing Date: 2025-07-02
Form Type: S-4/A
Source: 0001193125-25-154936
Chunk: 37

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-07-02
Form: S-4/A
Chunk 37
---
 of Denali to satisfy Nasdaq’s continued listing requirements pursuant to Nasdaq Listing Rule 5450(b)(2)(A) and Listing Rule IM-5101-2(b). |

| • |     | “Nasdaq Listing Rules” means the rules and listing standards of Nasdaq. |

| • |     | “New Semnur Board” means the board of directors of New Semnur. |

| • |     | “New Semnur Certificate of Designations” means the Certificate of Designations of Semnur Pharmaceuticals, Inc. to be in effect immediately prior to the Effective Time, a copy of which is attached as Annex G, designating the series of preferred stock, par value $0.0001 per share, of New Semnur as “Series A Preferred Stock”. |

| • |     | “New Semnur Common Stock” means the common stock, par value $0.0001 per share, of (i) Denali immediately after the Domestication and prior to the Effective Time, and (ii) New Semnur, following the Effective Time. |

| • |     | “New Semnur Series A Preferred Stock” means the preferred stock, par value $0.0001 per share, of (i) Semnur, following the Domestication and the filing of the New Semnur Certificate of Designations designating a series of preferred stock as Series A Preferred Stock prior to the Effective Time, and (ii) New Semnur, following the Effective Time. |

| • |     | “New Semnur Warrants” means the redeemable warrants that entitle the holder thereof to purchase one share of (i) Denali immediately after the Domestication and prior to the Effective Time, and (ii) New Semnur, following the Effective Time. |

| • |     | “Oramed” means Oramed Pharmaceuticals, Inc. |

| • |     | “OTC Markets” means the OTC Markets Group, Inc. |

| • |     | “OTC Markets Listing Date” means the first date on which the Public Units, Denali Class A Ordinary Shares and Public Warrants commence trading on the OTC Markets. |

| • |     | “Proposed Bylaws” means the Amended and Restated Bylaws of Semnur Pharmaceuticals, Inc., a copy of which is attached as Annex C. |

| • |     | “Proposed Charter” means the Amended and Restated Certificate